10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,877 | -26.1% | 1,694 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $94,592 | +0.1% | 1,694 | 0.0% | 0.01% | -6.7% |
| Q1 2023 | $94,508 | +69.7% | 1,694 | +10.9% | 0.02% | +66.7% |
| Q4 2022 | $55,680 | -99.9% | 1,528 | +12.4% | 0.01% | +28.6% |
| Q3 2022 | $38,732,000 | -8.5% | 1,360 | +45.5% | 0.01% | 0.0% |
| Q2 2022 | $42,308,000 | -15.7% | 935 | +41.7% | 0.01% | -12.5% |
| Q1 2022 | $50,206,000 | -48.9% | 660 | 0.0% | 0.01% | -46.7% |
| Q4 2021 | $98,313,000 | +2.3% | 660 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $96,082,000 | -25.7% | 660 | 0.0% | 0.02% | -31.8% |
| Q2 2021 | $129,241,000 | +8.2% | 660 | 0.0% | 0.02% | -4.3% |
| Q1 2021 | $119,460,000 | +27.8% | 660 | 0.0% | 0.02% | +15.0% |
| Q4 2020 | $93,456,000 | – | 660 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |